Wells Fargo Upgrades Tandem Diabetes Care to Overweight, Raises Price Target to $27

Benzinga Newsdesk www.benzinga.com Positive 87.5%

Neg 0% Neu 0% Pos 87.5%

Wells Fargo analyst Larry Biegelsen upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Equal-Weight to Overweight and raises the price target from $21 to $27.